UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054185
Receipt number R000061874
Scientific Title Evaluation of qualitative imaging techniques after autologous cultured chondrocyte implantation
Date of disclosure of the study information 2024/05/01
Last modified on 2024/04/18 12:30:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of qualitative imaging techniques after autologous cultured chondrocyte implantation

Acronym

Evaluation of qualitative imaging techniques after autologous cultured chondrocyte implantation

Scientific Title

Evaluation of qualitative imaging techniques after autologous cultured chondrocyte implantation

Scientific Title:Acronym

Evaluation of qualitative imaging techniques after autologous cultured chondrocyte implantation

Region

Japan


Condition

Condition

cartilage injury of knee joint

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We evaluate the effectiveness of qualitative MRI in transplanted tissue after Autologous cultured Chondrocyte Implantation for articular cartilage injury of knee joint.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Postoperative time correlates with T1rho map and T2map values on qualitative MRI examination, qualitative MRI can detect the condition of transplanted tissue 0 to 20 years after autologous cultured chondrocyte implantation.

Key secondary outcomes

Morphological MRI images and MOCART score
Clinical scores VAS, koos score, Lysholm score, WOMAC


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Qualitative MRI will be performed on patients who have undergone autologous cultured chondrocyte transplantation for knee cartilage injury after 0-20 years between March 2017 and September 2019.
T1rho map and T2 map will be measured from the obtained images.
Morphological MRI images are taken under the same conditions.The MOCART score is calculated from the obtained images.
Clinical scores (Lysholm score, KOOS score, IKDC score, WOMAC score) are calculated under the same conditions.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

70 years-old >=

Gender

Male and Female

Key inclusion criteria

An autologous cultured chondrocyte transplantation was performed for a knee joint cartilage injury.
A postoperative qualitative MRI scan was performed.

Key exclusion criteria

Imaging tests with qualitative measurements could not be performed or the data were poor.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Taku
Middle name
Last name Tadenuma

Organization

Shimane University

Division name

Faculty of Medicine, department of Rehabilitation medicine

Zip code

693-8501

Address

Enya89-1, Izumo city, Shimane prefecture

TEL

0853-88-3047

Email

tadenuma@med.shimmane-u.ac.jp


Public contact

Name of contact person

1st name Taku
Middle name
Last name Tadenuma

Organization

Shimane University

Division name

Faculty of Medicine, department of Rehabilitation medicine

Zip code

693-8501

Address

Enya89-1, Izumo city, Shimane prefecture

TEL

0853-88-3047

Homepage URL


Email

tadenuma@med.shimmane-u.ac.jp


Sponsor or person

Institute

Shimane University

Institute

Department

Personal name



Funding Source

Organization

Shimane University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Research Ethics Committee, Shimane University Faculty of Medicine

Address

Enya89-1, Izumo city, Shimane prefecture

Tel

0853202515

Email

kenkyu@med.shiamne-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 04 Month 10 Day

Date of IRB

2024 Year 04 Month 10 Day

Anticipated trial start date

2024 Year 05 Month 01 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 04 Month 18 Day

Last modified on

2024 Year 04 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061874